AntiCoag-AF Application icon

AntiCoag-AF 4.0

1 MB / 0+ Downloads / Rating 5.0 - 1 reviews


See previous versions

AntiCoag-AF, developed and published by CereScape, has released its latest version, 4.0, on 2022-02-02. This app falls under the Medical category on the Google Play Store and has achieved over 10 installs. It currently holds an overall rating of 5.0, based on 1 reviews.

AntiCoag-AF APK available on this page is compatible with all Android devices that meet the required specifications (Android 2.3+). It can also be installed on PC and Mac using an Android emulator such as Bluestacks, LDPlayer, and others.

Read More

App Screenshot

App Screenshot

App Details

Package name: com.cerescape.darby.anticoag_af

Updated: 3 years ago

Developer Name: CereScape

Category: Medical

New features: Show more

Installation Instructions

This article outlines two straightforward methods for installing AntiCoag-AF on PC Windows and Mac.

Using BlueStacks

  1. Download the APK/XAPK file from this page.
  2. Install BlueStacks by visiting http://bluestacks.com.
  3. Open the APK/XAPK file by double-clicking it. This action will launch BlueStacks and begin the application's installation. If the APK file does not automatically open with BlueStacks, right-click on it and select 'Open with...', then navigate to BlueStacks. Alternatively, you can drag-and-drop the APK file onto the BlueStacks home screen.
  4. Wait a few seconds for the installation to complete. Once done, the installed app will appear on the BlueStacks home screen. Click its icon to start using the application.

Using LDPlayer

  1. Download and install LDPlayer from https://www.ldplayer.net.
  2. Drag the APK/XAPK file directly into LDPlayer.

If you have any questions, please don't hesitate to contact us.

Previous Versions

AntiCoag-AF 4.0
2022-02-02 / 1 MB / Android 2.3+

About this app

This application is for medical practitioners who need to quickly review which anticoagulant (including the direct oral anticoagulants (DOACs)) to use to prevent stroke in patients with non-valvular atrial fibrillation (NVAF).

It contains relevant information about warfarin, apixaban, dabigatran and rivaroxaban.

Privacy policy is at www.cerescape.com/privacy/

Topics covered include: comparison of anticoagulants, patient information, when anticoagulation is required, risk-benefit issues, when warfarin is appropriate, how to choose the dose of a NOAC, starting or switching between anticoagulants, clinical monitoring, bleeding risks, use of antiplatelet agents in addition to oral anticoagulants, managing ischemic strokes on NOACs, reversing anticoagulation in the event of intracerebral haemorrhage, and peri-operative management information.

Information contained within the application was edited by Dr Bruce Campbell. Coding was by CereScape (www.cerescape.com). It is our aim to keep this information current, and we welcome constructive comments and evidenced updated information. Any profit generated by this application will be used to fund stroke research.

New features

Updated content including new information on reversal of DOACs.